NCT03352544

Brief Summary

The purpose of this randomized controlled trial is to study the effects of exercise on body weight, body composition, anthropometric and fasting blood measures, physical fitness, pulmonary function, quality of life, and lifestyle habits in patients with severe mental illness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2015

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 16, 2015

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 5, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 23, 2015

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

November 10, 2017

Completed
14 days until next milestone

First Posted

Study publicly available on registry

November 24, 2017

Completed
Last Updated

September 5, 2018

Status Verified

September 1, 2018

Enrollment Period

5 months

First QC Date

November 10, 2017

Last Update Submit

September 3, 2018

Conditions

Outcome Measures

Primary Outcomes (8)

  • Body weight

    In kilograms. Using the InBody 770 Body Composition Analyzer (Biospace Ltd, Seoul, Korea)

    12 weeks

  • Fat mass

    In kilograms. Using the InBody 770 Body Composition Analyzer (Biospace Ltd, Seoul, Korea)

    12 weeks

  • Lean mass

    In kilograms. Using the InBody 770 Body Composition Analyzer (Biospace Ltd, Seoul, Korea)

    12 weeks

  • Waist girth

    In millimeters. Using a measuring tape (Harpenden Anthropometric Tape; Holtain, Dyfed, UK) placed at the midpoint between the last rib and the iliac crest

    12 weeks

  • Hip girth

    In millimeters. Using a measuring tape (Harpenden Anthropometric Tape; Holtain, Dyfed, UK) placed atthe maximum width over the greater trochanters

    12 weeks

  • Blood glucose

    In milligram per deciliter. Collected in the morning after an overnight fast

    12 weeks

  • Blood cholesterol

    In milligram per deciliter. Collected in the morning after an overnight fast

    12 weeks

  • Blood triglyceride

    In milligram per deciliter. Collected in the morning after an overnight fast

    12 weeks

Secondary Outcomes (16)

  • Lower body strength

    12 weeks

  • Upper body strength

    12 weeks

  • Aerobic endurance

    12 weeks

  • Lower body flexibility

    12 weeks

  • Upper body flexibility

    12 weeks

  • +11 more secondary outcomes

Study Arms (2)

Exercise

EXPERIMENTAL

Exercise training for 12 weeks (aerobic and resistance training trice a week).

Behavioral: Exercise

Usual treatment

NO INTERVENTION

Usual treatment during 12 weeks, coinciding with exercise intervention time frame.

Interventions

ExerciseBEHAVIORAL

Exercise training for 12 weeks (aerobic and resistance training trice a week)

Also known as: Exercise training
Exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with severe mental illness established by experienced psychiatrists, aged 18 years or older and stabilized on antipsychotic medication during the last month.

You may not qualify if:

  • Patients with clinical instability, co-morbid substance abuse, or evidence of uncontrolled cardiovascular, neuromuscular and endocrine disorders.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Pablo de Olavide

Seville, Spain

Location

MeSH Terms

Interventions

Exercise

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 10, 2017

First Posted

November 24, 2017

Study Start

March 16, 2015

Primary Completion

August 5, 2015

Study Completion

December 23, 2015

Last Updated

September 5, 2018

Record last verified: 2018-09

Locations